A STUDY ON ANXIETY AND DEPRESSION AMONG PATIENTS WITH POLYCYSTIC OVARY SYNDROME

  • Rahul Radhakrishnan Department of Pharmacy Practice, Vinayaka Mission’s College of Pharmacy, Vinayaka Mission’s Research Foundation, Salem Tamilnadu-636008, India
  • Anna Verghese Department of Clinical Pharmacy, Malabar Cancer Centre, Kannur, Kerala, india

Abstract

Background: Patients with polycystic ovarian syndrome (PCOS) often suffer from psychiatric co-morbidities, such as anxiety and depression. The prevalence of PCOS is increasing In India.


Objective: To Study anxiety and depression among PCOS Patients.


Materials and Methods: It was a cross-sectional observational study, which was conducted in Obstetrics and Gynaecology department of a tertiary care hospital. Patients diagnosed with PCOS were assessed on hospital anxiety depression scale and sociodemographic and clinical information was gathered using semi-structured questionnaire.


Result: The prevalence of anxiety of 36% and depression 16% were observed.


Discussion: PCOS patients were found to have high prevalence of anxiety and depression due to the Symptoms of PCOS.


Keywords: Anxiety, PCOS, psychological problems, Depression

Downloads

Download data is not yet available.

Author Biographies

Rahul Radhakrishnan, Department of Pharmacy Practice, Vinayaka Mission’s College of Pharmacy, Vinayaka Mission’s Research Foundation, Salem Tamilnadu-636008, India

Department of Pharmacy Practice, Vinayaka Mission’s College of Pharmacy, Vinayaka Mission’s Research Foundation, Salem Tamilnadu-636008, India

Anna Verghese, Department of Clinical Pharmacy, Malabar Cancer Centre, Kannur, Kerala, india

Department of Clinical Pharmacy, Malabar Cancer Centre, Kannur, Kerala, india

References

1. Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women. J Clin Endocrinol Metab 1999; 84:1897–9.
2. Solomon CG. The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks. Endocrinol Metab Clin North Am 1999; 28: 247–63.
3. Kitzinger C, Willmott J. “The thief of womanhood”: women’s experience of polycystic ovarian syndrome. Soc Sci Med 2002; 54:349–61.
4. Snyder BS. The lived experience of women diagnosed with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs 2006; 35: 385–92.
5. Dokras A, Clifton S, Futterweit W, Wild RA. Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis. Obstet Gynecol 2011; 117:145–52.
6. Kerchner A, Lester W, Stuart SP, Dokras A. Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil Steril 2009; 91:207–12.
7. Brawman-Mintzer O, Lydiard RB, Emmanuel N, Payeur R, Johnson M, Roberts J, et al. Psychiatric comorbidity in patients with generalized anxiety disorder.Am J Psychiatry 1993; 150:1216–8.
8. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62:617–27 [erratum: Arch Gen Psychiatry 2005; 62:709].
9. Kessler RC, Ruscio AM, Shear K, Wittchen HU. Epidemiology of anxiety disorders [review]. Curr Top Behav Neurosci 2010; 2:21–35.
10. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results. J Psychosom Res 1997; 42:17–41.
11. Månsson M, Holte J, Landin-Wilhelmsen K, Dahlgren E, Johansson A, Landén M. Women with polycystic ovary syndrome are often depressed or anxious – a case control study. Psychoneuroendocrinology 2008; 33:1132–8.
12. Kerchner A, Lester W, Stuart SP, Dokras A. Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil Steril 2009; 91:207–12
13. Lipton MG, Sherr L, Elford J, Rustin MH, Clayton WJ. Women living with facial hair: the psychological and behavioral burden. J Psychosom Res 2006; 61:161–8.
14. Yazici K, Baz K, Yazici AE, Köktürk A, Tot S, Demirseren D, et al. Disease-specific quality of life is associated with anxiety and depression in patients with acne. J Eur Acad Dermatol Venereol. 2004; 18:435–9.
15. Petry NM, Barry D, Pietrzak RH, Wagner JA. Overweight and obesity are associated with psychiatric disorders: results from the National Epidemiologic Survey on alcohol and related conditions. Psychosom Med 2008; 70:288–97.
16. Rassi A, Veras AB, dos Reis M, Pastore DL, Bruno LM, Bruno RV, et al. Prevalence of psychiatric disorders in patients with polycystic ovary syndrome. Compr Psychiatry. 2010; 51:599–602.
17. Hollinrake E, Abreu A, Maifeld M, Van Voorhis BJ, Dokras A. Increased risk of depressive disorders in women with polycystic ovary syndrome. Fertil Steril. 2007; 87:1369–76.
Statistics
30 Views | 37 Downloads
How to Cite
Radhakrishnan, R., & Verghese, A. (2018). A STUDY ON ANXIETY AND DEPRESSION AMONG PATIENTS WITH POLYCYSTIC OVARY SYNDROME. Journal of Drug Delivery and Therapeutics, 8(5-s), 338-340. https://doi.org/10.22270/jddt.v8i5-s.1988
Section
Research